Twitter Facebook LinkedIn YouTube

Canna-V-Cell Sciences (CSE:CNVC) New Listing

Video Platform Video Management Video Solutions Video Player

Based in Vancouver, British Columbia, Canna-V-Cell Sciences is the exclusive Cannabis worldwide licensee of the proprietary and patent protected Bio Harvest Technology.

Additional Information:

Company: Canna-V-Cell Sciences
Stock Symbol: CSE: CNVC
Date Published: Nov 20, 2018
Transcript: Available

Video Transcript:

I’m Megan Edwards for Investmentpitch Media

Canna-V-Cell Sciences, formerly known as Midnight Star Ventures, through its subsidiary in Israel, has received authorization from the health ministry of Israel to conduct research and development with Cannabis plants.

Dr. Yochi Hagay, CTO, stated: "This is a major milestone in the adaptation of the cell growth technology to Cannabis. Our ability to conduct our lab activities directly with the plant allows us to accelerate the program and validate the biofarming technology with Cannabis."

Dr. Zaki Rakib, CEO, added: "We are glad to have received such authorization a month ahead of the plan. The team is totally committed to the success of the program which is set to revolutionize the Cannabis industry.”

Based in Vancouver, British Columbia, Canna-V-Cell Sciences is the exclusive Cannabis worldwide licensee of the proprietary and patent protected Bio Harvest Technology.

Bio Harvest Technology is a platform technology for growth of plant cells in Bio reactors.

Bio Harvest expended approximately US$15 million to develop the technology over a period of 7 years.

It is the first and only industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity of growing the plant itself.

By adopting this technology and building adequate cell production capacity, Canna-V-Cell's objective is to become the leading supplier of Cannabis for both the medicinal and recreational legal use.

The company recently appointed Alan Rootenberg as CFO.

As CFO and Director of Empower Clinics, a leading owner and operator of medical cannabis clinics and developer of medical products in the US, Alan was involved in transitioning this chain of US based privately held medical cannabis clinics into a publicly traded entity.

The shares are trading at $0.30.

For more information, please contact David Ryan at 604-622-1186 or email midnight.star.ventures@gmail.com.

I’m Megan Edwards for Investmentpitch Media